Cargando…
The Prevalence, Characteristics and Risk Factors of Persistent Symptoms in Non-Hospitalized and Hospitalized Children with SARS-CoV-2 Infection Followed-Up for up to 12 Months: A Prospective, Cohort Study in Rome, Italy
Previous studies assessing the prevalence of COVID-19 sequelae in children have included either a small number of children or a short follow-up period, or have only focused on hospitalized children. We investigated the prevalence of persistent symptoms amongst children and assessed the risk factors,...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692851/ https://www.ncbi.nlm.nih.gov/pubmed/36431250 http://dx.doi.org/10.3390/jcm11226772 |
_version_ | 1784837373193879552 |
---|---|
author | Buonsenso, Danilo Pazukhina, Ekaterina Gentili, Carolina Vetrugno, Luigi Morello, Rosa Zona, Margherita De Matteis, Alessia D’Ilario, Federico Lanni, Roberta Rongai, Teresa del Balzo, Patrizia Fonte, Maria Teresa Valente, Michele De Rose, Cristina Munblit, Daniel Sigfrid, Louise Valentini, Piero |
author_facet | Buonsenso, Danilo Pazukhina, Ekaterina Gentili, Carolina Vetrugno, Luigi Morello, Rosa Zona, Margherita De Matteis, Alessia D’Ilario, Federico Lanni, Roberta Rongai, Teresa del Balzo, Patrizia Fonte, Maria Teresa Valente, Michele De Rose, Cristina Munblit, Daniel Sigfrid, Louise Valentini, Piero |
author_sort | Buonsenso, Danilo |
collection | PubMed |
description | Previous studies assessing the prevalence of COVID-19 sequelae in children have included either a small number of children or a short follow-up period, or have only focused on hospitalized children. We investigated the prevalence of persistent symptoms amongst children and assessed the risk factors, including the impact of variants. A prospective cohort study included children (≤18 years old) with PCR-confirmed SARS-CoV-2 infection. The participants were assessed via telephone and face-to-face visits at 1–5, 6–9 and 12 or more months post-SARS-CoV-2 diagnosis using the ISARIC COVID-19 follow-up survey. Of the 679 children enrolled, 51% were female; 488 were infected during the wild virus wave, and 29 were infected with the Alpha, 42 with the Delta and 120 with the Omicron variants. Fatigue (19%), headache (12%), insomnia (7.5%), muscle pain (6.9%) and confusion with concentration issues (6.8%) were the most common persistent symptoms. Families reported an overall improvement over time, with 0.7% of parents interviewed at 12 months or more of the follow-up period reporting a poor recovery. Patients that had not recovered by 6–9 months had a lower probability of recovering during the next follow-up period. Children infected with a variant or the wild virus had an overall similar rate of persistent symptoms (although the pattern of reported symptoms differed significantly) and recovery rates. Conclusions: Recovery rates after SARS-CoV-2 infection improved as time passed from the initial infection, ranging from 4% of children having poor recovery at 1–5 months’ follow-up to 1.3% at 6–9 months and 0.7% at 12 months. The patterns of persistence changed according to the variants involved at the time of infection. This study reinforces that a subgroup of children develop long-lasting persistent symptoms and highlights the need for further studies investigating the reasons behind the development of PCC. |
format | Online Article Text |
id | pubmed-9692851 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96928512022-11-26 The Prevalence, Characteristics and Risk Factors of Persistent Symptoms in Non-Hospitalized and Hospitalized Children with SARS-CoV-2 Infection Followed-Up for up to 12 Months: A Prospective, Cohort Study in Rome, Italy Buonsenso, Danilo Pazukhina, Ekaterina Gentili, Carolina Vetrugno, Luigi Morello, Rosa Zona, Margherita De Matteis, Alessia D’Ilario, Federico Lanni, Roberta Rongai, Teresa del Balzo, Patrizia Fonte, Maria Teresa Valente, Michele De Rose, Cristina Munblit, Daniel Sigfrid, Louise Valentini, Piero J Clin Med Article Previous studies assessing the prevalence of COVID-19 sequelae in children have included either a small number of children or a short follow-up period, or have only focused on hospitalized children. We investigated the prevalence of persistent symptoms amongst children and assessed the risk factors, including the impact of variants. A prospective cohort study included children (≤18 years old) with PCR-confirmed SARS-CoV-2 infection. The participants were assessed via telephone and face-to-face visits at 1–5, 6–9 and 12 or more months post-SARS-CoV-2 diagnosis using the ISARIC COVID-19 follow-up survey. Of the 679 children enrolled, 51% were female; 488 were infected during the wild virus wave, and 29 were infected with the Alpha, 42 with the Delta and 120 with the Omicron variants. Fatigue (19%), headache (12%), insomnia (7.5%), muscle pain (6.9%) and confusion with concentration issues (6.8%) were the most common persistent symptoms. Families reported an overall improvement over time, with 0.7% of parents interviewed at 12 months or more of the follow-up period reporting a poor recovery. Patients that had not recovered by 6–9 months had a lower probability of recovering during the next follow-up period. Children infected with a variant or the wild virus had an overall similar rate of persistent symptoms (although the pattern of reported symptoms differed significantly) and recovery rates. Conclusions: Recovery rates after SARS-CoV-2 infection improved as time passed from the initial infection, ranging from 4% of children having poor recovery at 1–5 months’ follow-up to 1.3% at 6–9 months and 0.7% at 12 months. The patterns of persistence changed according to the variants involved at the time of infection. This study reinforces that a subgroup of children develop long-lasting persistent symptoms and highlights the need for further studies investigating the reasons behind the development of PCC. MDPI 2022-11-16 /pmc/articles/PMC9692851/ /pubmed/36431250 http://dx.doi.org/10.3390/jcm11226772 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Buonsenso, Danilo Pazukhina, Ekaterina Gentili, Carolina Vetrugno, Luigi Morello, Rosa Zona, Margherita De Matteis, Alessia D’Ilario, Federico Lanni, Roberta Rongai, Teresa del Balzo, Patrizia Fonte, Maria Teresa Valente, Michele De Rose, Cristina Munblit, Daniel Sigfrid, Louise Valentini, Piero The Prevalence, Characteristics and Risk Factors of Persistent Symptoms in Non-Hospitalized and Hospitalized Children with SARS-CoV-2 Infection Followed-Up for up to 12 Months: A Prospective, Cohort Study in Rome, Italy |
title | The Prevalence, Characteristics and Risk Factors of Persistent Symptoms in Non-Hospitalized and Hospitalized Children with SARS-CoV-2 Infection Followed-Up for up to 12 Months: A Prospective, Cohort Study in Rome, Italy |
title_full | The Prevalence, Characteristics and Risk Factors of Persistent Symptoms in Non-Hospitalized and Hospitalized Children with SARS-CoV-2 Infection Followed-Up for up to 12 Months: A Prospective, Cohort Study in Rome, Italy |
title_fullStr | The Prevalence, Characteristics and Risk Factors of Persistent Symptoms in Non-Hospitalized and Hospitalized Children with SARS-CoV-2 Infection Followed-Up for up to 12 Months: A Prospective, Cohort Study in Rome, Italy |
title_full_unstemmed | The Prevalence, Characteristics and Risk Factors of Persistent Symptoms in Non-Hospitalized and Hospitalized Children with SARS-CoV-2 Infection Followed-Up for up to 12 Months: A Prospective, Cohort Study in Rome, Italy |
title_short | The Prevalence, Characteristics and Risk Factors of Persistent Symptoms in Non-Hospitalized and Hospitalized Children with SARS-CoV-2 Infection Followed-Up for up to 12 Months: A Prospective, Cohort Study in Rome, Italy |
title_sort | prevalence, characteristics and risk factors of persistent symptoms in non-hospitalized and hospitalized children with sars-cov-2 infection followed-up for up to 12 months: a prospective, cohort study in rome, italy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692851/ https://www.ncbi.nlm.nih.gov/pubmed/36431250 http://dx.doi.org/10.3390/jcm11226772 |
work_keys_str_mv | AT buonsensodanilo theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT pazukhinaekaterina theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT gentilicarolina theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT vetrugnoluigi theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT morellorosa theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT zonamargherita theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT dematteisalessia theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT dilariofederico theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT lanniroberta theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT rongaiteresa theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT delbalzopatrizia theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT fontemariateresa theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT valentemichele theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT derosecristina theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT munblitdaniel theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT sigfridlouise theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT valentinipiero theprevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT buonsensodanilo prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT pazukhinaekaterina prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT gentilicarolina prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT vetrugnoluigi prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT morellorosa prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT zonamargherita prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT dematteisalessia prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT dilariofederico prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT lanniroberta prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT rongaiteresa prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT delbalzopatrizia prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT fontemariateresa prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT valentemichele prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT derosecristina prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT munblitdaniel prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT sigfridlouise prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly AT valentinipiero prevalencecharacteristicsandriskfactorsofpersistentsymptomsinnonhospitalizedandhospitalizedchildrenwithsarscov2infectionfollowedupforupto12monthsaprospectivecohortstudyinromeitaly |